Leading biotechnology firm Biocon Ltd launched a new kind of diabetic drug that will help the patients to control their blood sugar levels all day long. While speaking about the new drug called Basalog, Biocon chief Kiran Mazumdar-Shaw said that it is the first diabetic drug that works for 24 hours. The company stated that Basalog will be available in Indian market in 10ml and 3ml vials.

 

According to Kiran, over the years diabetes has emerged as the most menacing disease for a large chunk of world population. She added the disease has a very strong foothold in India. With the introduction of Basalog, the biotechnology company has taken an initiative to provide best of diabetes management and care in India, said Kiran.

 

Informing about the new diabetic drug, Biocon chief said that Basalog has 24-hour long peek less action, which is first of its kind in the country. Unlike other insulin, Basalog has the flexibility of injection timing and it ensures effective HbA1c control, added Kiran. The cases of diabetes are highest in India. As per an estimate, the country has the world's largest diabetic population, around 40 million.